REQUEST A DEMO
Total
USD $0.00
Search more companies

Unidad de Hematologia y Oncologia de Santander S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Unidad de Hematologia y Oncologia de Santander S.A.S. Profile Updated: May 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Unidad de Hematologia y Oncologia de Santander S.A.S. is based in Colombia. The head office is in Bucaramanga. The company operates in the Ambulatory Health Care Services sector. Unidad de Hematologia y Oncologia de Santander S.A.S. was incorporated on August 04, 2010. There are currently 20 (2024) people employed by Unidad de Hematologia y Oncologia de Santander S.A.S.. The company’s latest financial report indicates a net sales revenue drop of 19.38% in 2023. Its’ total assets recorded a growth of 1.12%. In 2023, Unidad de Hematologia y Oncologia de Santander S.A.S.’s net profit margin decreased by 5.77%.

Headquarters
Cra. 36 # 48-98
Bucaramanga; Santander;

Contact Details: Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.

Website: http://www.unidhos.com.co

Basic Information
Total Employees:
Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.
Outstanding Shares:
Purchase the Unidad de Hematologia y Oncologia de Santander S.A.S. report to view the information.
Incorporation Date:
August 04, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Unidad de Hematologia y Oncologia de Santander S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-19.38%
Total operating revenue
-19.38%
Operating profit (EBIT)
16.06%
EBITDA
21.59%
Net Profit (Loss) for the Period
-10.11%
Total assets
1.12%
Total equity
-65.02%
Operating Profit Margin (ROS)
-0.44%
Net Profit Margin
-5.77%
Return on Equity (ROE)
-126.83%
Debt to Equity Ratio
56.49%
Quick Ratio
-0.08%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?